LIMES
ActiveSummary
LIMES has been active since 1990 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €76,757 and a net result of €5,748. Equity is growing by ~17.4% per year across the filed fiscal years. Its solvency ranks better than 16% of 2151 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2024
Axes · tick = 2023
Profitability70▼-1
Solvency41▲+2
Growth52=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €4,500 at 30 days acceptable
Liquidity tight (current ratio 1.05 against 0.98 in 2023; short-term debt: 83.6% and cash: 14% of total assets), and 83.6% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2024Solvency, return and age of the figures
Solvency
16.4%
Return on assets
1.2%
Age of the figures
21 mo
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 16% of 2151 sector peers (2024).
NBB · sector comparisonPosition among 2151 sector peers
Solvency
better than 16%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 02-07-2025, 29 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
not confirmed
2024
29 d early
2023
30 d early
2022
27 d early
2021
31 d early
2020
30 d early
2019
30 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 6 accounts on average 30 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (1)
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What other support did companies like this one receive, and it did not?Public money How does this company compare with its sector?Sector benchmark
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2024, abbreviated schema
Turnover
€805,000▼ 17.6%
2018 · €976,500
EBIT margin
2.1%▲ 0.6pp
2018 · 1.5%
Net result
€5,748▼ 37.1%
2023 · €9,136
Working capital
€19,542
2023 · -€8,616
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20202021202220232024
Turnover
Operating result€7,688▼ 54.5%€14,935▲ 94.3%€22,050▲ 47.6%€19,687▼ 10.7%€17,464▼ 11.3%
Net result€4,006below the sector's middle half▲ 24.1%€9,372below the sector's middle half▲ 134%€13,429below the sector's middle half▲ 43.3%€9,136below the sector's middle half▼ 32.0%€5,748below the sector's middle half▼ 37.1%
EBIT margin
Equity€39,072below the sector's middle half▲ 11.4%€48,444below the sector's middle half▲ 24.0%€61,872below the sector's middle half▲ 27.7%€71,009below the sector's middle half▲ 14.8%€76,757below the sector's middle half▲ 8.1%
Total assets€579,141within the sector's middle half▼ 7.6%€499,490within the sector's middle half▼ 13.8%€486,841within the sector's middle half▼ 2.5%€518,987within the sector's middle half▲ 6.6%€468,497below the sector's middle half▼ 9.7%
Debt€468,273▼ 9.9%€379,250▼ 19.0%€349,452▼ 7.9%€447,979▲ 28.2%€391,740▼ 12.6%
Working capital€20,353▼ 14.0%€85,339▲ 319%€50,520▼ 40.8%-€8,616€19,542
Solvency6.7%below the sector's middle half▲ 1.2pp9.7%below the sector's middle half▲ 3.0pp12.7%below the sector's middle half▲ 3.0pp13.7%below the sector's middle half▲ 1.0pp16.4%below the sector's middle half▲ 2.7pp
Staff (FTE)2.9within the sector's middle half▼ 71.3%2.7within the sector's middle half▼ 6.9%3within the sector's middle half▲ 11.1%6within the sector's middle half▲ 100%4.9within the sector's middle half▼ 18.3%
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Why a figure moved sharply
- 2020 Staff (FTE) -71% on 2019. The accounts now follow the abbreviated schema, last year the full schema.
Result per fiscal year
Operating resultNet result
The operating result has fallen two years in a row; 2024 is 11% below 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €468,497
Fixed assets
€57,214 ▼ 28.1%
Current assets
€411,283 ▼ 6.4%
Equity and liabilities €468,497
Equity
€76,757 ▲ 8.1%
Debt
€391,740 ▼ 12.6%
Debt's share of the balance-sheet total falls from 86.3% to 83.6%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€40,511▼
2023 · €43,073
Cash flow
€28,795▼
2023 · €32,522
Current ratio
1.05▲
2023 · 0.98
Debt to equity
5.10▼
2023 · 6.31
ROE
7.5%▼
2023 · 12.9%
ROA
1.2%▼
2023 · 1.8%
Interest coverage
8.44▼
2023 · 16.15
Debt ≤ 1 year
€391,740▼
2023 · €447,979
Income taxes
€6,916▼
2023 · €7,902
Staff costs
€480,591▼
2023 · €599,027
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 3,980 companies that looked in July 2024 the way this one looks now, 1.1% went bankrupt within 24 months and 96% are still going.
- Micro
- 20 years or older
- solvency 10 to 30%
- a profit under 5% of the balance sheet
1.1%
went bankrupt
2.2%
stopped otherwise
96%
still going
A further 0.2% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a lower bankruptcy probability: 0.1% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,662 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.4% |
| 3 | 0.5% | 0.5% |
| 4 | 0.6% | 0.7% |
| 5 | 0.8% | 0.9% |
| 6 | 1.2% | 1.3% |
| 7 | 1.5% | 1.7% |
| 8 | 1.7% | 1.7% |
| 9 | 2.7% | 2.8% |
| 10 | 5.3% | 5.7% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 75% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 3,980 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Remuneration, social security and pensions62 | - | €260,478 | €288,018 | €599,027 | €480,591 | ▼ 19.8% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €55,777 | €56,233 | €24,879 | €23,386 | €23,047 | ▼ 1.4% |
| Provisions for liabilities and charges: additions (uses and reversals)635/8 | - | - | €3,720 | -€75,516 | - | - |
| Other operating charges640/8 | - | €511 | €413 | €731 | €715 | ▼ 2.2% |
| Gross operating margin9900 | €331,992 | €332,156 | €339,079 | €567,315 | €521,817 | ▼ 8.0% |
| Operating profit (loss)9901 | €7,688 | €14,935 | €22,050 | €19,687 | €17,464 | ▼ 11.3% |
| Financial income75/76B | - | €0 | €139 | €19 | - | - |
| Recurring financial income75 | €836 | €0 | €139 | €19 | - | - |
| Financial charges65/66B | - | €985 | €1,009 | €2,668 | €4,800 | ▲ 79.9% |
| Recurring financial charges65 | €752 | €985 | €1,009 | €2,668 | €4,800 | ▲ 79.9% |
| Profit (loss) for the period before taxes9903 | €7,771 | €13,949 | €21,180 | €17,039 | €12,664 | ▼ 25.7% |
| Income taxes67/77 | €3,765 | €4,577 | €7,751 | €7,902 | €6,916 | ▼ 12.5% |
| Profit (loss) for the period9904 | €4,006 | €9,372 | €13,429 | €9,136 | €5,748 | ▼ 37.1% |
| Profit (loss) for the period to be appropriated9905 | €4,006 | €9,372 | €13,429 | €9,136 | €5,748 | ▼ 37.1% |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €579,141 | €499,490 | €486,841 | €518,987 | €468,497 | ▼ 9.7% |
| Fixed assets21/28 | €90,515 | €34,900 | €86,868 | €79,625 | €57,214 | ▼ 28.1% |
| Intangible fixed assets21 | €12,655 | €3,145 | €2,216 | €1,634 | €1,139 | ▼ 30.3% |
| Tangible fixed assets22/27 | €77,860 | €31,755 | €84,652 | €77,992 | €56,075 | ▼ 28.1% |
| Plant, machinery and equipment23 | - | - | - | €1,630 | €1,228 | ▼ 24.7% |
| Furniture and vehicles24 | - | €31,755 | €84,652 | €76,361 | €54,848 | ▼ 28.2% |
| Current assets29/58 | €488,626 | €464,590 | €399,972 | €439,362 | €411,283 | ▼ 6.4% |
| Amounts receivable after more than one year29 | - | - | - | €243,674 | - | - |
| Trade receivables290 | - | - | - | €243,389 | - | - |
| Other amounts receivable291 | - | - | - | €285 | - | - |
| Amounts receivable within one year40/41 | €407,623 | €381,438 | €179,863 | - | €334,678 | - |
| Trade receivables40 | - | €381,437 | €179,863 | - | €334,056 | - |
| Other amounts receivable41 | - | €1 | - | - | €622 | - |
| Cash at bank and in hand54/58 | €49,398 | €61,155 | €198,388 | €179,415 | €65,581 | ▼ 63.4% |
| Deferred charges and accrued income490/1 | - | €21,997 | €21,721 | €16,274 | €11,024 | ▼ 32.3% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €579,141 | €499,490 | €486,841 | €518,987 | €468,497 | ▼ 9.7% |
| Equity10/15 | €39,072 | €48,444 | €61,872 | €71,009 | €76,757 | ▲ 8.1% |
| Contributions10/11 | - | €24,789 | €24,789 | €24,789 | €24,789 | = |
| Reserves13 | €329 | €329 | €329 | €329 | €329 | = |
| Non-distributable reserves130/1 | - | €329 | €329 | - | - | - |
| Reserves not available under the articles1311 | - | €329 | €329 | - | - | - |
| Distributable reserves133 | - | - | - | €329 | €329 | = |
| Profit (loss) carried forward14 | €13,953 | €23,325 | €36,754 | €45,890 | €51,638 | ▲ 12.5% |
| Provisions and deferred taxes16 | €71,796 | €71,796 | €75,516 | - | - | - |
| Provisions for liabilities and charges160/5 | - | €71,796 | €75,516 | - | - | - |
| Pensions and similar obligations160 | - | €71,796 | €75,516 | - | - | - |
| Amounts payable17/49 | €468,273 | €379,250 | €349,452 | €447,979 | €391,740 | ▼ 12.6% |
| Amounts payable within one year42/48 | €468,273 | €379,250 | €349,452 | €447,979 | €391,740 | ▼ 12.6% |
| Trade debts44 | €34,213 | €64,157 | €35,306 | €75,375 | €32,357 | ▼ 57.1% |
| Suppliers440/4 | - | €64,157 | €35,306 | €75,375 | €32,357 | ▼ 57.1% |
| Taxes, remuneration and social security45 | - | €65,093 | €64,146 | €122,604 | €109,383 | ▼ 10.8% |
| Taxes450/3 | - | €30,292 | €21,313 | €40,691 | €39,742 | ▼ 2.3% |
| Remuneration and social security454/9 | - | €34,801 | €42,833 | €81,912 | €69,641 | ▼ 15.0% |
| Other amounts payable47/48 | - | €250,000 | €250,000 | €250,000 | €250,000 | = |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €4,006 | €9,372 | €13,429 | €9,136 | €5,748 | ▼ 37.1% |
| + Depreciation and write-downs630 | €55,777 | €56,233 | €24,879 | €23,386 | €23,047 | ▼ 1.4% |
| Operating cash flow (approximation) | €59,783 | €65,605 | €38,308 | €32,522 | €28,795 | ▼ 11.5% |
| Investment in fixed assets (approximation) | - | -€618 | -€76,847 | -€16,143 | -€637 | ▲ 96.1% |
| Change in cash | - | €11,756 | €137,233 | -€18,973 | -€113,834 | ▼ 500% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
2026
06-07
State Gazette act
Resignation: VOF Maconim (managing director)Appointment: William Reynders (day-to-day manager) · Legal form clause · Director discharge6 facts ▸
State Gazette act
Resignation: VOF Maconim (managing director)
Appointment: William Reynders (day-to-day manager) · Legal form clause · Director discharge6 facts ▸
- Legal form clause, besloten vennootschap
- Board meeting, 16-04-2026
- Director resignation, VOF Maconim (managing director)
- Director discharge, Patrick Siborgs (managing director)
- Director appointment, William Reynders (day-to-day manager)
- Power of attorney, BV Partoens Van Haute Advocaten
2025
02-07
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
01-07
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
04-07
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
31-12
Financial
Highest result since 2018net €13,429 ▲43.3%
Operating result €22,050, net result €13,429, both a record.
30-06
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
01-07
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
01-07
NBB filing
Annual accounts filed
fiscal year 2019 · full schema
2019
31-12
Financial
Weakest financial yearnet €3,229 ▼24.2%
Net result drops to €3,229, the lowest in the series; recovery starts the following year.
03-07
NBB filing
Annual accounts filed
fiscal year 2018 · full schema
2018
02-07
NBB filing
Annual accounts filed
fiscal year 2017 · full schema
2017
27-06
NBB filing
Annual accounts filed
fiscal year 2016 · full schema
2016
22-06
NBB filing
Annual accounts filed
fiscal year 2015 · full schema
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
1 of 17 acts read
About the unread acts
Of the 17 Belgian State Gazette acts we know for this company, 1 has been read. The other 16 have not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
1 office holder, last change in 2026
Day-to-day management 1
William Reynders
CurrentDay-to-day manager · since 06-07-2026
Derived from published Gazette acts. The CBE keeps the official list of function holders; we do not read it, so the two can differ.
See the function holders in the CBE →
Not every act has been read: a resignation may be missing here
16 of this company's 17 Belgian State Gazette acts have not been read yet. Appointments and resignations recorded in them are missing above: a director who resigned there may therefore still show here as sitting. The acts are in the Timeline.
Location & real-estate footprint
Registered office, Hasselt · 1 establishment unit since 1990
Ground area
8,031 m²
Building footprint
3,417 m²
Parcel 71327G0302/00M000, Flanders. Linked by address, not a title deed.
30
companies at this address
See who is registered here
1 establishment unit
LIMES
since 19902.050.149.834
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 71327G0302/00M000 | Flanders | 8,031 m² | 1 · 3,417 m² | - |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Mandate history
2 people since 2026, 1 in office
- Day-to-day management
- began earlier
| Name | Functions and periods |
|---|---|
| William Reynders |
|
| VOF Maconim |
|
Structure & network
Connections & network
1 current directorThe network starts from this company’s directors. Other companies they run appear here as nodes.
This company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, scroll to zoom.
Public money · subsidies and aid
Flemish government
2022 to 2023 · 2 entries · 2,691 EUR awarded · 2,691 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2023 | 1 | 441 EUR | 441 EUR |
| 2022 | 1 | 2,250 EUR | 2,250 EUR |
Similar companies · same sector, comparable size
Dr. M. Veys
BE 0765.264.573
Brugge · Eq €80,455
Unité Jolimont
BE 0748.968.276
La Louvière · Eq €67,258
LECLERCQ ORTHOPEDIE
BE 0737.426.860
Braine-le-Château · Eq €63,986
SANCHEZTHESIA
BE 0751.634.984
Etterbeek · Eq €112,023
Behrmed
BE 0675.805.730
Brussel · Eq €204,903
Of 157 companies in sector 86101 we hold annual accounts for 82. 19 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded08-08-1990
Fiscal year end31-12
Activities, NACEBEL 2025
72109Other research and development on natural sciences
86101Human health activities
E-invoicing
Reachable via Peppol
Peppol ID
0208:0441727409
Also
9925:BE0441727409
Registered
17-12-2025
Register as of 27 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.